GHRP-2 and ipamorelin are siblings at the same ghrelin receptor, and the comparison is really about manners: GHRP-2 pushes a stronger growth-hormone pulse and drags hunger, cortisol, and prolactin along; ipamorelin releases less GH more cleanly. That trade decided the market years ago. What neither ever produced is outcome evidence or a lawful supply.
The comparison
| GHRP-2 | Ipamorelin | |
|---|---|---|
| Receptor | Ghrelin (GHS-R1a) | Ghrelin (GHS-R1a) |
| GH pulse strength | Stronger | Moderate |
| Off-target effects | Appetite spike, cortisol and prolactin elevation | Minimal: the selectivity that made its name |
| Human evidence | Old pharmacology studies; no outcomes | Same story, plus an abandoned pharma program |
| Regulatory status | Never approved; research chemical | Never approved; explicitly FDA Category 2 |
| Sport | WADA-prohibited | WADA-prohibited |
The practical folklore follows the pharmacology: GHRP-2 appears in mass-gain lore precisely because of the hunger it triggers; ipamorelin became the clinic default because patients did not want cortisol and appetite side effects attached to a wellness protocol. Both facts are about tolerability, not results: no controlled trial shows body-composition outcomes for either in healthy adults.
The verdict logic
If someone insists on choosing inside this class, selectivity wins on side-effect grounds and ipamorelin is the rational pick, which is exactly what the clinic market concluded. But the 2026 frame matters more than the matchup: ipamorelin's Category 2 designation closed its compounding lane, GHRP-2 never had one, and the whole class is prohibited in sport. The comparison worth making is against tesamorelin, the one GHRH-axis drug with approval and outcome data, or against not doing this at all.
Frequently asked questions
Which is stronger, GHRP-2 or ipamorelin?
GHRP-2 produces the larger GH pulse, at the cost of hunger, cortisol, and prolactin elevation. Ipamorelin trades peak strength for selectivity. Strength of pulse has never translated into demonstrated body-composition outcomes for either.
Why does GHRP-2 make you hungry?
It stimulates the ghrelin receptor with less selectivity: ghrelin is the hunger hormone, and GHRP-2 activates that signaling alongside GH release. Ipamorelin's engineering largely avoids it.
Are GHRP-2 and ipamorelin legal?
Neither is approved; ipamorelin sits explicitly in FDA Category 2, and GHRP-2 has no compounding basis either. Selling either for human use is unlawful, and both are WADA-prohibited at all times.